Global Hypertension RDN Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 103

Published Date: 16 May 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Hypertension RDN Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Renal denervation (also called renal ablation) is a minimally invasive, investigational procedure to treat hypertension (high blood pressure) that hasn't improved with other treatments. This type of hypertension is called resistant hypertension
This report is a detailed and comprehensive analysis for global Hypertension RDN Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Hypertension RDN Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Hypertension RDN Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Hypertension RDN Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Hypertension RDN Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hypertension RDN Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hypertension RDN Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, ReCor Medical, Sonivies, Covidien and Boston Scientific, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Hypertension RDN Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    r-Renal Denervation(rRDN)
    u-Renal Denervation(uRDN)

Market segment by Application
    Hospital
    Clinic
    Others

Market segment by players, this report covers
    Medtronic
    ReCor Medical
    Sonivies
    Covidien
    Boston Scientific
    Johnson & Johnson
    Terumo Corporation
    Angiocare
    Shanghai Golden Leaf Med Tec
    Shanghai Bio-Heart Biological Technology
    Xinmai Medical Equipment
    Microport Ep Medtech
    Cryofocus Medtech

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Hypertension RDN Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hypertension RDN Therapy, with revenue, gross margin and global market share of Hypertension RDN Therapy from 2018 to 2023.
Chapter 3, the Hypertension RDN Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Hypertension RDN Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Hypertension RDN Therapy.
Chapter 13, to describe Hypertension RDN Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Hypertension RDN Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Hypertension RDN Therapy by Type
        1.3.1 Overview: Global Hypertension RDN Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Hypertension RDN Therapy Consumption Value Market Share by Type in 2022
        1.3.3 r-Renal Denervation(rRDN)
        1.3.4 u-Renal Denervation(uRDN)
    1.4 Global Hypertension RDN Therapy Market by Application
        1.4.1 Overview: Global Hypertension RDN Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Others
    1.5 Global Hypertension RDN Therapy Market Size & Forecast
    1.6 Global Hypertension RDN Therapy Market Size and Forecast by Region
        1.6.1 Global Hypertension RDN Therapy Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Hypertension RDN Therapy Market Size by Region, (2018-2029)
        1.6.3 North America Hypertension RDN Therapy Market Size and Prospect (2018-2029)
        1.6.4 Europe Hypertension RDN Therapy Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Hypertension RDN Therapy Market Size and Prospect (2018-2029)
        1.6.6 South America Hypertension RDN Therapy Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Hypertension RDN Therapy Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Medtronic
        2.1.1 Medtronic Details
        2.1.2 Medtronic Major Business
        2.1.3 Medtronic Hypertension RDN Therapy Product and Solutions
        2.1.4 Medtronic Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Medtronic Recent Developments and Future Plans
    2.2 ReCor Medical
        2.2.1 ReCor Medical Details
        2.2.2 ReCor Medical Major Business
        2.2.3 ReCor Medical Hypertension RDN Therapy Product and Solutions
        2.2.4 ReCor Medical Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 ReCor Medical Recent Developments and Future Plans
    2.3 Sonivies
        2.3.1 Sonivies Details
        2.3.2 Sonivies Major Business
        2.3.3 Sonivies Hypertension RDN Therapy Product and Solutions
        2.3.4 Sonivies Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Sonivies Recent Developments and Future Plans
    2.4 Covidien
        2.4.1 Covidien Details
        2.4.2 Covidien Major Business
        2.4.3 Covidien Hypertension RDN Therapy Product and Solutions
        2.4.4 Covidien Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Covidien Recent Developments and Future Plans
    2.5 Boston Scientific
        2.5.1 Boston Scientific Details
        2.5.2 Boston Scientific Major Business
        2.5.3 Boston Scientific Hypertension RDN Therapy Product and Solutions
        2.5.4 Boston Scientific Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Boston Scientific Recent Developments and Future Plans
    2.6 Johnson & Johnson
        2.6.1 Johnson & Johnson Details
        2.6.2 Johnson & Johnson Major Business
        2.6.3 Johnson & Johnson Hypertension RDN Therapy Product and Solutions
        2.6.4 Johnson & Johnson Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Johnson & Johnson Recent Developments and Future Plans
    2.7 Terumo Corporation
        2.7.1 Terumo Corporation Details
        2.7.2 Terumo Corporation Major Business
        2.7.3 Terumo Corporation Hypertension RDN Therapy Product and Solutions
        2.7.4 Terumo Corporation Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Terumo Corporation Recent Developments and Future Plans
    2.8 Angiocare
        2.8.1 Angiocare Details
        2.8.2 Angiocare Major Business
        2.8.3 Angiocare Hypertension RDN Therapy Product and Solutions
        2.8.4 Angiocare Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Angiocare Recent Developments and Future Plans
    2.9 Shanghai Golden Leaf Med Tec
        2.9.1 Shanghai Golden Leaf Med Tec Details
        2.9.2 Shanghai Golden Leaf Med Tec Major Business
        2.9.3 Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Product and Solutions
        2.9.4 Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Shanghai Golden Leaf Med Tec Recent Developments and Future Plans
    2.10 Shanghai Bio-Heart Biological Technology
        2.10.1 Shanghai Bio-Heart Biological Technology Details
        2.10.2 Shanghai Bio-Heart Biological Technology Major Business
        2.10.3 Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Product and Solutions
        2.10.4 Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Shanghai Bio-Heart Biological Technology Recent Developments and Future Plans
    2.11 Xinmai Medical Equipment
        2.11.1 Xinmai Medical Equipment Details
        2.11.2 Xinmai Medical Equipment Major Business
        2.11.3 Xinmai Medical Equipment Hypertension RDN Therapy Product and Solutions
        2.11.4 Xinmai Medical Equipment Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Xinmai Medical Equipment Recent Developments and Future Plans
    2.12 Microport Ep Medtech
        2.12.1 Microport Ep Medtech Details
        2.12.2 Microport Ep Medtech Major Business
        2.12.3 Microport Ep Medtech Hypertension RDN Therapy Product and Solutions
        2.12.4 Microport Ep Medtech Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Microport Ep Medtech Recent Developments and Future Plans
    2.13 Cryofocus Medtech
        2.13.1 Cryofocus Medtech Details
        2.13.2 Cryofocus Medtech Major Business
        2.13.3 Cryofocus Medtech Hypertension RDN Therapy Product and Solutions
        2.13.4 Cryofocus Medtech Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Cryofocus Medtech Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Hypertension RDN Therapy Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Hypertension RDN Therapy by Company Revenue
        3.2.2 Top 3 Hypertension RDN Therapy Players Market Share in 2022
        3.2.3 Top 6 Hypertension RDN Therapy Players Market Share in 2022
    3.3 Hypertension RDN Therapy Market: Overall Company Footprint Analysis
        3.3.1 Hypertension RDN Therapy Market: Region Footprint
        3.3.2 Hypertension RDN Therapy Market: Company Product Type Footprint
        3.3.3 Hypertension RDN Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Hypertension RDN Therapy Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Hypertension RDN Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Hypertension RDN Therapy Consumption Value Market Share by Application (2018-2023)
    5.2 Global Hypertension RDN Therapy Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Hypertension RDN Therapy Consumption Value by Type (2018-2029)
    6.2 North America Hypertension RDN Therapy Consumption Value by Application (2018-2029)
    6.3 North America Hypertension RDN Therapy Market Size by Country
        6.3.1 North America Hypertension RDN Therapy Consumption Value by Country (2018-2029)
        6.3.2 United States Hypertension RDN Therapy Market Size and Forecast (2018-2029)
        6.3.3 Canada Hypertension RDN Therapy Market Size and Forecast (2018-2029)
        6.3.4 Mexico Hypertension RDN Therapy Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Hypertension RDN Therapy Consumption Value by Type (2018-2029)
    7.2 Europe Hypertension RDN Therapy Consumption Value by Application (2018-2029)
    7.3 Europe Hypertension RDN Therapy Market Size by Country
        7.3.1 Europe Hypertension RDN Therapy Consumption Value by Country (2018-2029)
        7.3.2 Germany Hypertension RDN Therapy Market Size and Forecast (2018-2029)
        7.3.3 France Hypertension RDN Therapy Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Hypertension RDN Therapy Market Size and Forecast (2018-2029)
        7.3.5 Russia Hypertension RDN Therapy Market Size and Forecast (2018-2029)
        7.3.6 Italy Hypertension RDN Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Hypertension RDN Therapy Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Hypertension RDN Therapy Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Hypertension RDN Therapy Market Size by Region
        8.3.1 Asia-Pacific Hypertension RDN Therapy Consumption Value by Region (2018-2029)
        8.3.2 China Hypertension RDN Therapy Market Size and Forecast (2018-2029)
        8.3.3 Japan Hypertension RDN Therapy Market Size and Forecast (2018-2029)
        8.3.4 South Korea Hypertension RDN Therapy Market Size and Forecast (2018-2029)
        8.3.5 India Hypertension RDN Therapy Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Hypertension RDN Therapy Market Size and Forecast (2018-2029)
        8.3.7 Australia Hypertension RDN Therapy Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Hypertension RDN Therapy Consumption Value by Type (2018-2029)
    9.2 South America Hypertension RDN Therapy Consumption Value by Application (2018-2029)
    9.3 South America Hypertension RDN Therapy Market Size by Country
        9.3.1 South America Hypertension RDN Therapy Consumption Value by Country (2018-2029)
        9.3.2 Brazil Hypertension RDN Therapy Market Size and Forecast (2018-2029)
        9.3.3 Argentina Hypertension RDN Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Hypertension RDN Therapy Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Hypertension RDN Therapy Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Hypertension RDN Therapy Market Size by Country
        10.3.1 Middle East & Africa Hypertension RDN Therapy Consumption Value by Country (2018-2029)
        10.3.2 Turkey Hypertension RDN Therapy Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Hypertension RDN Therapy Market Size and Forecast (2018-2029)
        10.3.4 UAE Hypertension RDN Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Hypertension RDN Therapy Market Drivers
    11.2 Hypertension RDN Therapy Market Restraints
    11.3 Hypertension RDN Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Hypertension RDN Therapy Industry Chain
    12.2 Hypertension RDN Therapy Upstream Analysis
    12.3 Hypertension RDN Therapy Midstream Analysis
    12.4 Hypertension RDN Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Hypertension RDN Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Hypertension RDN Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Hypertension RDN Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Hypertension RDN Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Medtronic Company Information, Head Office, and Major Competitors
    Table 6. Medtronic Major Business
    Table 7. Medtronic Hypertension RDN Therapy Product and Solutions
    Table 8. Medtronic Hypertension RDN Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Medtronic Recent Developments and Future Plans
    Table 10. ReCor Medical Company Information, Head Office, and Major Competitors
    Table 11. ReCor Medical Major Business
    Table 12. ReCor Medical Hypertension RDN Therapy Product and Solutions
    Table 13. ReCor Medical Hypertension RDN Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. ReCor Medical Recent Developments and Future Plans
    Table 15. Sonivies Company Information, Head Office, and Major Competitors
    Table 16. Sonivies Major Business
    Table 17. Sonivies Hypertension RDN Therapy Product and Solutions
    Table 18. Sonivies Hypertension RDN Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Sonivies Recent Developments and Future Plans
    Table 20. Covidien Company Information, Head Office, and Major Competitors
    Table 21. Covidien Major Business
    Table 22. Covidien Hypertension RDN Therapy Product and Solutions
    Table 23. Covidien Hypertension RDN Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Covidien Recent Developments and Future Plans
    Table 25. Boston Scientific Company Information, Head Office, and Major Competitors
    Table 26. Boston Scientific Major Business
    Table 27. Boston Scientific Hypertension RDN Therapy Product and Solutions
    Table 28. Boston Scientific Hypertension RDN Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Boston Scientific Recent Developments and Future Plans
    Table 30. Johnson & Johnson Company Information, Head Office, and Major Competitors
    Table 31. Johnson & Johnson Major Business
    Table 32. Johnson & Johnson Hypertension RDN Therapy Product and Solutions
    Table 33. Johnson & Johnson Hypertension RDN Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Johnson & Johnson Recent Developments and Future Plans
    Table 35. Terumo Corporation Company Information, Head Office, and Major Competitors
    Table 36. Terumo Corporation Major Business
    Table 37. Terumo Corporation Hypertension RDN Therapy Product and Solutions
    Table 38. Terumo Corporation Hypertension RDN Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Terumo Corporation Recent Developments and Future Plans
    Table 40. Angiocare Company Information, Head Office, and Major Competitors
    Table 41. Angiocare Major Business
    Table 42. Angiocare Hypertension RDN Therapy Product and Solutions
    Table 43. Angiocare Hypertension RDN Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Angiocare Recent Developments and Future Plans
    Table 45. Shanghai Golden Leaf Med Tec Company Information, Head Office, and Major Competitors
    Table 46. Shanghai Golden Leaf Med Tec Major Business
    Table 47. Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Product and Solutions
    Table 48. Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Shanghai Golden Leaf Med Tec Recent Developments and Future Plans
    Table 50. Shanghai Bio-Heart Biological Technology Company Information, Head Office, and Major Competitors
    Table 51. Shanghai Bio-Heart Biological Technology Major Business
    Table 52. Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Product and Solutions
    Table 53. Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Shanghai Bio-Heart Biological Technology Recent Developments and Future Plans
    Table 55. Xinmai Medical Equipment Company Information, Head Office, and Major Competitors
    Table 56. Xinmai Medical Equipment Major Business
    Table 57. Xinmai Medical Equipment Hypertension RDN Therapy Product and Solutions
    Table 58. Xinmai Medical Equipment Hypertension RDN Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Xinmai Medical Equipment Recent Developments and Future Plans
    Table 60. Microport Ep Medtech Company Information, Head Office, and Major Competitors
    Table 61. Microport Ep Medtech Major Business
    Table 62. Microport Ep Medtech Hypertension RDN Therapy Product and Solutions
    Table 63. Microport Ep Medtech Hypertension RDN Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Microport Ep Medtech Recent Developments and Future Plans
    Table 65. Cryofocus Medtech Company Information, Head Office, and Major Competitors
    Table 66. Cryofocus Medtech Major Business
    Table 67. Cryofocus Medtech Hypertension RDN Therapy Product and Solutions
    Table 68. Cryofocus Medtech Hypertension RDN Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Cryofocus Medtech Recent Developments and Future Plans
    Table 70. Global Hypertension RDN Therapy Revenue (USD Million) by Players (2018-2023)
    Table 71. Global Hypertension RDN Therapy Revenue Share by Players (2018-2023)
    Table 72. Breakdown of Hypertension RDN Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 73. Market Position of Players in Hypertension RDN Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 74. Head Office of Key Hypertension RDN Therapy Players
    Table 75. Hypertension RDN Therapy Market: Company Product Type Footprint
    Table 76. Hypertension RDN Therapy Market: Company Product Application Footprint
    Table 77. Hypertension RDN Therapy New Market Entrants and Barriers to Market Entry
    Table 78. Hypertension RDN Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 79. Global Hypertension RDN Therapy Consumption Value (USD Million) by Type (2018-2023)
    Table 80. Global Hypertension RDN Therapy Consumption Value Share by Type (2018-2023)
    Table 81. Global Hypertension RDN Therapy Consumption Value Forecast by Type (2024-2029)
    Table 82. Global Hypertension RDN Therapy Consumption Value by Application (2018-2023)
    Table 83. Global Hypertension RDN Therapy Consumption Value Forecast by Application (2024-2029)
    Table 84. North America Hypertension RDN Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 85. North America Hypertension RDN Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 86. North America Hypertension RDN Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 87. North America Hypertension RDN Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 88. North America Hypertension RDN Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 89. North America Hypertension RDN Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 90. Europe Hypertension RDN Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 91. Europe Hypertension RDN Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 92. Europe Hypertension RDN Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 93. Europe Hypertension RDN Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 94. Europe Hypertension RDN Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 95. Europe Hypertension RDN Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 96. Asia-Pacific Hypertension RDN Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 97. Asia-Pacific Hypertension RDN Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 98. Asia-Pacific Hypertension RDN Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 99. Asia-Pacific Hypertension RDN Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 100. Asia-Pacific Hypertension RDN Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 101. Asia-Pacific Hypertension RDN Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 102. South America Hypertension RDN Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 103. South America Hypertension RDN Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 104. South America Hypertension RDN Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 105. South America Hypertension RDN Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 106. South America Hypertension RDN Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 107. South America Hypertension RDN Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 108. Middle East & Africa Hypertension RDN Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 109. Middle East & Africa Hypertension RDN Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 110. Middle East & Africa Hypertension RDN Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 111. Middle East & Africa Hypertension RDN Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 112. Middle East & Africa Hypertension RDN Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 113. Middle East & Africa Hypertension RDN Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 114. Hypertension RDN Therapy Raw Material
    Table 115. Key Suppliers of Hypertension RDN Therapy Raw Materials
List of Figures
    Figure 1. Hypertension RDN Therapy Picture
    Figure 2. Global Hypertension RDN Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Hypertension RDN Therapy Consumption Value Market Share by Type in 2022
    Figure 4. r-Renal Denervation(rRDN)
    Figure 5. u-Renal Denervation(uRDN)
    Figure 6. Global Hypertension RDN Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Hypertension RDN Therapy Consumption Value Market Share by Application in 2022
    Figure 8. Hospital Picture
    Figure 9. Clinic Picture
    Figure 10. Others Picture
    Figure 11. Global Hypertension RDN Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Hypertension RDN Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Market Hypertension RDN Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 14. Global Hypertension RDN Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 15. Global Hypertension RDN Therapy Consumption Value Market Share by Region in 2022
    Figure 16. North America Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 17. Europe Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 18. Asia-Pacific Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. South America Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Middle East and Africa Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. Global Hypertension RDN Therapy Revenue Share by Players in 2022
    Figure 22. Hypertension RDN Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 23. Global Top 3 Players Hypertension RDN Therapy Market Share in 2022
    Figure 24. Global Top 6 Players Hypertension RDN Therapy Market Share in 2022
    Figure 25. Global Hypertension RDN Therapy Consumption Value Share by Type (2018-2023)
    Figure 26. Global Hypertension RDN Therapy Market Share Forecast by Type (2024-2029)
    Figure 27. Global Hypertension RDN Therapy Consumption Value Share by Application (2018-2023)
    Figure 28. Global Hypertension RDN Therapy Market Share Forecast by Application (2024-2029)
    Figure 29. North America Hypertension RDN Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 30. North America Hypertension RDN Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 31. North America Hypertension RDN Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 32. United States Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 33. Canada Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 34. Mexico Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 35. Europe Hypertension RDN Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 36. Europe Hypertension RDN Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 37. Europe Hypertension RDN Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 38. Germany Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 39. France Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 40. United Kingdom Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 41. Russia Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 42. Italy Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 43. Asia-Pacific Hypertension RDN Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 44. Asia-Pacific Hypertension RDN Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 45. Asia-Pacific Hypertension RDN Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 46. China Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 47. Japan Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 48. South Korea Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 49. India Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 50. Southeast Asia Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 51. Australia Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 52. South America Hypertension RDN Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 53. South America Hypertension RDN Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 54. South America Hypertension RDN Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 55. Brazil Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 56. Argentina Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 57. Middle East and Africa Hypertension RDN Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 58. Middle East and Africa Hypertension RDN Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 59. Middle East and Africa Hypertension RDN Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 60. Turkey Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 61. Saudi Arabia Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 62. UAE Hypertension RDN Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 63. Hypertension RDN Therapy Market Drivers
    Figure 64. Hypertension RDN Therapy Market Restraints
    Figure 65. Hypertension RDN Therapy Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Hypertension RDN Therapy in 2022
    Figure 68. Manufacturing Process Analysis of Hypertension RDN Therapy
    Figure 69. Hypertension RDN Therapy Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Medtronic
ReCor Medical
Sonivies
Covidien
Boston Scientific
Johnson & Johnson
Terumo Corporation
Angiocare
Shanghai Golden Leaf Med Tec
Shanghai Bio-Heart Biological Technology
Xinmai Medical Equipment
Microport Ep Medtech
Cryofocus Medtech

Related Reports

Global Hypertension RDN Therapy Supply, Demand and Key Producers, 2023-2029

Global Hypertension RDN Therapy Supply, Demand and Key Producers, 2023-2029

date 16 May 2023

date Medical Care

The global Hypertension RDN Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Hypertension RDN Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Hypertension RDN Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 16 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Hypertension RDN Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Hypertension RDN Therapy Supply, Demand and Key Producers, 2024-2030

Global Hypertension RDN Therapy Supply, Demand and Key Producers, 2024-2030

date 21 Feb 2024

date Medical Care

The global Hypertension RDN Therapy market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Hypertension RDN Therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>